Moderna (MRNA) announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, October 19-22, 2025, in ...
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it gave a late-breaking ...
CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...
It’s a virus that caused a global pandemic, and getting vaccinated against it has been a growing source of controversy. While ...
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop ...
MedPage Today on MSN
Don't Fear Oseltamivir in Kids Hospitalized With Flu
Kids who received oseltamivir during their flu-related hospitalization were 31% less likely to be admitted to the ICU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback